Retractable Technologies, Inc. (NYSEMKT:RVP) insider Thomas J. Shaw bought 20,000 shares of the firm’s stock in a transaction on Monday, October 23rd. The shares were bought at an average cost of $0.62 per share, with a total value of $12,400.00. Following the purchase, the insider now directly owns 13,103,642 shares in the company, valued at $8,124,258.04. The transaction was disclosed in a filing with the SEC, which is available at this hyperlink.

Shares of Retractable Technologies, Inc. (NYSEMKT RVP) traded up 1.61% during midday trading on Monday, hitting $0.63. 357,635 shares of the company’s stock were exchanged. Retractable Technologies, Inc. has a 52 week low of $0.54 and a 52 week high of $2.69. The company has a 50-day moving average of $0.62 and a 200-day moving average of $0.97. The firm’s market cap is $19.95 million.

Retractable Technologies (NYSEMKT:RVP) last released its quarterly earnings results on Monday, August 14th. The company reported ($0.05) EPS for the quarter. Retractable Technologies had a negative return on equity of 22.24% and a negative net margin of 17.65%. The business had revenue of $7.65 million for the quarter. Equities research analysts expect that Retractable Technologies, Inc. will post ($0.46) EPS for the current fiscal year.

COPYRIGHT VIOLATION NOTICE: This news story was first reported by American Banking News and is owned by of American Banking News. If you are reading this news story on another site, it was copied illegally and reposted in violation of US and international trademark and copyright law. The correct version of this news story can be viewed at https://www.americanbankingnews.com/2017/10/23/insider-buying-retractable-technologies-inc-rvp-insider-purchases-20000-shares-of-stock.html.

A hedge fund recently raised its stake in Retractable Technologies stock. WealthTrust Axiom LLC increased its holdings in shares of Retractable Technologies, Inc. (NYSEMKT:RVP) by 6.8% during the second quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 583,062 shares of the company’s stock after acquiring an additional 36,898 shares during the quarter. WealthTrust Axiom LLC owned about 1.84% of Retractable Technologies worth $740,000 as of its most recent filing with the SEC.

Separately, ValuEngine raised shares of Retractable Technologies from a “sell” rating to a “hold” rating in a research note on Monday, October 2nd.

About Retractable Technologies

Retractable Technologies, Inc designs, develops and manufactures safety medical products for the healthcare industry. The Company markets VanishPoint and PatientSafe products. The VanishPoint products are designed specifically to prevent needle stick injuries and to prevent reuse. The VanishPoint safety products include tuberculin, insulin and allergy antigen VanishPoint syringes; 0.5mL, 1mL, 2mL, 3mL, 5mL and 10mL VanishPoint syringes, and the VanishPoint autodisable syringe.

Receive News & Ratings for Retractable Technologies Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Retractable Technologies Inc. and related companies with MarketBeat.com's FREE daily email newsletter.